The Correlation Between Gut Microbiome/Metabolite and End Stage Renal Disease (ESRD)

NCT03010696 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 293

Last updated 2020-10-22

No results posted yet for this study

Summary

The purpose of this study is to investigate the differences of gut Microbiome/Metabolite between ESRD patients and healthy subjects. Two hundred and twenty three hemodialysis patients and 70 healthy subjects are recruited, and a cross-sectional study is performed.

Conditions

  • Kidney Failure, Chronic

Interventions

OTHER

No interventions, questionnaire, collect specimen

Sponsors & Collaborators

  • Peking University Aerospace Center Hospital

    collaborator OTHER
  • General Hospital of Chinese Armed Police Forces

    collaborator OTHER
  • Beijing Anzhen Hospital

    collaborator OTHER
  • Peking University Shougang Hospital

    collaborator OTHER
  • Beijing Heyiyuan Biotech Co. Ltd.

    collaborator OTHER
  • Shenzhen Microbiota Technology Co. Ltd.

    collaborator UNKNOWN
  • China Agricultural University

    lead OTHER

Principal Investigators

  • Fazheng Ren, PhD · China Agricultural Universtiy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-07-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03010696 on ClinicalTrials.gov